Lars Schimmoller

Duesseldorf, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 128 publications

Confirmation of Prostate-specific Antigen (PSA) Values Improves Prostate Cancer Screening in Early Middle-Aged Men - Data from the PROBASE Trial.

Confirmation of Prostate-specific Antigen (PSA) Values Improves Prostate Cancer Screening in Early Middle-Aged Men - Data from the PROBASE Trial.

Journal: European urology
Published: April 15, 2026

Reducing overdiagnosis-how to do I correctly assess the indication for prostate biopsy?

Reducing overdiagnosis-how to do I correctly assess the indication for prostate biopsy?

Journal: Urologie (Heidelberg, Germany)
Published: April 01, 2026

MRI Quality and Reader Experience in Organized Prostate Cancer Screening: Insights from the PROBASE Trial.

MRI Quality and Reader Experience in Organized Prostate Cancer Screening: Insights from the PROBASE Trial.

Journal: European urology oncology
Published: March 08, 2026

Magnetic resonance imaging of hand involvement in polymyalgia rheumatica: a comparison with seropositive rheumatoid arthritis.

Magnetic resonance imaging of hand involvement in polymyalgia rheumatica: a comparison with seropositive rheumatoid arthritis.

Journal: RMD open
Published: February 13, 2026

Biparametric versus multiparametric magnetic resonance imaging for the diagnosis of prostate cancer

Biparametric versus multiparametric magnetic resonance imaging for the diagnosis of prostate cancer

Journal: Urologie (Heidelberg, Germany)
Published: January 14, 2026

PRIMA: randomized prospective multicenter non-inferiority study for primary diagnosis of clinically significant PRostate cancer by PSA and MR IMAging-study protocol for a randomized diagnostic accuracy trial.

PRIMA: randomized prospective multicenter non-inferiority study for primary diagnosis of clinically significant PRostate cancer by PSA and MR IMAging-study protocol for a randomized diagnostic accuracy trial.

Journal: Trials
Published: November 06, 2025

Diagnostic value of prostate magnetic resonance imaging in men with prostate-specific antigen levels ≥ 15 ng/mL for biopsy decision-making.

Diagnostic value of prostate magnetic resonance imaging in men with prostate-specific antigen levels ≥ 15 ng/mL for biopsy decision-making.

Journal: Insights into imaging
Published: November 01, 2025

Risk-adapted Prostate Cancer Screening Achieves Mammography-like Benefits: Evidence and Implications for Europe.

Risk-adapted Prostate Cancer Screening Achieves Mammography-like Benefits: Evidence and Implications for Europe.

Journal: European urology
Published: October 23, 2025

Analysis of Operator Expertise in MRI/TRUS Fusion-Guided Prostate Biopsy.

Analysis of Operator Expertise in MRI/TRUS Fusion-Guided Prostate Biopsy.

Journal: Cancers
Published: October 05, 2025

Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis: The PRIME Diagnostic Clinical Trial.

Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis: The PRIME Diagnostic Clinical Trial.

Journal: JAMA
Published: September 10, 2025

Value of Additional Systematic Cores During Magnetic Resonance Imaging-guided Targeted Biopsy in Prostate Cancer Screening for Young Men: Results from the PROBASE Trial.

Value of Additional Systematic Cores During Magnetic Resonance Imaging-guided Targeted Biopsy in Prostate Cancer Screening for Young Men: Results from the PROBASE Trial.

Journal: European urology oncology
Published: August 17, 2025

The Pelvic Rosetta Classification Project: An Interdisciplinary Proposal for a Lymph Node Map of the Pelvis in Prostate Cancer.

The Pelvic Rosetta Classification Project: An Interdisciplinary Proposal for a Lymph Node Map of the Pelvis in Prostate Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 26, 2025
Showing 1-12 of 128

Last Updated: 09/26/2026